Browsing: investment

Labcorp Holdings Inc. (NYSE:LH) earns fees from routine and specialty medical tests and laboratory services supporting drug development. Physicians, hospitals, and pharmaceutical companies provide different sources of demand, while personalized treatments create opportunities for more sophisticated testing. Capturing that demand requires spending on equipment, technology, and capacity before the resulting cash arrives.